Chongqing Lummy Pharmaceutical (300006) — Net Asset Momentum
Chongqing Lummy Pharmaceutical (300006) recorded a net asset momentum of -11.3% as of December 2024, with net assets of CN¥1.88 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Chongqing Lummy Pharmaceutical (300006) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Chongqing Lummy Pharmaceutical Net Asset Momentum (2006–2024)
This chart tracks Chongqing Lummy Pharmaceutical's year-over-year net asset growth across 19 annual reporting periods from 2006 to 2024. The most recent momentum reading is -11.3%, with net assets of CN¥1.88 Billion CNY as of December 2024. Read Chongqing Lummy Pharmaceutical balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Chongqing Lummy Pharmaceutical (2006–2024)
The table below shows the complete annual net asset history for Chongqing Lummy Pharmaceutical from 2006 to 2024, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Chongqing Lummy Pharmaceutical market cap and net worth.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥1.88 Billion | CN¥2.86 Billion | CN¥972.47 Million | ▼ -11.3% |
| 2023 | CN¥2.12 Billion | CN¥2.89 Billion | CN¥768.71 Million | ▼ -2.9% |
| 2022 | CN¥2.18 Billion | CN¥3.05 Billion | CN¥870.02 Million | ▼ -1.2% |
| 2021 | CN¥2.21 Billion | CN¥2.93 Billion | CN¥714.65 Million | ▲ +79.6% |
| 2020 | CN¥1.23 Billion | CN¥3.15 Billion | CN¥1.92 Billion | ▼ -25.5% |
| 2019 | CN¥1.65 Billion | CN¥3.50 Billion | CN¥1.85 Billion | ▼ -4.1% |
| 2018 | CN¥1.72 Billion | CN¥3.14 Billion | CN¥1.42 Billion | ▲ +0.1% |
| 2017 | CN¥1.72 Billion | CN¥2.74 Billion | CN¥1.02 Billion | ▲ +2.9% |
| 2016 | CN¥1.67 Billion | CN¥2.48 Billion | CN¥809.85 Million | ▼ -0.9% |
| 2015 | CN¥1.69 Billion | CN¥3.10 Billion | CN¥1.41 Billion | ▲ +66.2% |
| 2014 | CN¥1.02 Billion | CN¥2.24 Billion | CN¥1.23 Billion | ▼ -9.7% |
| 2013 | CN¥1.13 Billion | CN¥2.18 Billion | CN¥1.06 Billion | ▲ +58.4% |
| 2012 | CN¥710.51 Million | CN¥1.42 Billion | CN¥713.21 Million | ▲ +7.6% |
| 2011 | CN¥660.17 Million | CN¥1.08 Billion | CN¥420.81 Million | ▲ +17.6% |
| 2010 | CN¥561.59 Million | CN¥884.01 Million | CN¥322.42 Million | ▲ +7.0% |
| 2009 | CN¥525.08 Million | CN¥653.63 Million | CN¥128.55 Million | ▲ +281.1% |
| 2008 | CN¥137.79 Million | CN¥268.56 Million | CN¥130.77 Million | ▲ +27.7% |
| 2007 | CN¥107.91 Million | CN¥214.69 Million | CN¥106.78 Million | ▲ +67.6% |
| 2006 | CN¥64.39 Million | CN¥125.10 Million | CN¥60.72 Million | — |